|
1
|
Akhavanfard S, Yehia L, Padmanabhan R,
Reynolds JP, Ni Y and Eng C: Germline EGFR variants are
over-represented in adolescents and young adults (AYA) with
adrenocortical carcinoma. Hum Mol Genet. 29:3679–3690.
2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Jarzembowski JA: New prognostic indicators
in pediatric adrenal tumors: Neuroblastoma and adrenal cortical
tumors, can we predict when these will behave badly? Surg Pathol
Clin. 13:625–641. 2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Kamilaris CDC, Hannah-Shmouni F and
Stratakis CA: Adrenocortical tumorigenesis: Lessons from genetics.
Best Pract Res Clin Endocrinol Metab. 34(101428)2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Ribeiro TC, Jorge AA, Almeida MQ, Mariani
BM, Nishi MY, Mendonca BB, Fragoso MC and Latronico AC:
Amplification of the insulin-like growth factor 1 receptor gene is
a rare event in adrenocortical adenocarcinomas: Searching for
potential mechanisms of overexpression. Biomed Res Int.
2014(936031)2014.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Traynor MD Jr, Sada A, Thompson GB, Moir
CR, Bancos I, Farley DR, Dy BM, Lyden ML, Habermann EB and McKenzie
TJ: Adrenalectomy for non-neuroblastic pathology in children.
Pediatr Surg Int. 36:129–135. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Brondani VB and Fragoso MCBV: Pediatric
adrenocortical tumor-review and management update. Curr Opin
Endocrinol Diabetes Obes. 27:177–186. 2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Zekri W, Hammad M, Rashed WM, Ahmed G,
Elshafie M, Adly MH, Elborai Y, Abdalla B, Taha H, Elkinaae N, et
al: The outcome of childhood adrenocortical carcinoma in Egypt: A
model from developing countries. Pediatr Hematol Oncol. 37:198–210.
2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Longui CA: Adrenal cortical carcinoma in
infancy. Rev Paul Pediatr. 37:2–3. 2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Breidbart E, Cameo T, Garvin JH, Hibshoosh
H and Oberfield SE: Pubertal outcome in a female with virilizing
adrenocortical carcinoma. J Pediatr Endocrinol Metab. 29:503–509.
2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Erickson LA: Challenges in surgical
pathology of adrenocortical tumours. Histopathology. 72:82–96.
2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
De Martino MC, van Koetsveld PM, Feelders
RA, de Herder WW, Dogan F, Janssen JAMJL, Hofste Op Bruinink D,
Pivonello C, Waaijers AM, Colao A, et al: IGF and mTOR pathway
expression and in vitro effects of linsitinib and mTOR inhibitors
in adrenocortical cancer. Endocrine. 64:673–684. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Pinto EM, Zambetti GP and
Rodriguez-Galindo C: Pediatric adrenocortical tumours. Best Pract
Res Clin Endocrinol Metab. 34(101448)2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Kastenberg ZJ and Scaife ER:
Adrenocortical tumors in children. Semin Pediatr Surg.
29(150927)2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Sipayya V, Yadav YK, Arora R, Sharma U and
Gupta K: Virilizing adrenocortical carcinoma in a child: A rare
enigma. Indian J Endocrinol Metab. 16:621–623. 2012.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Khan MS, Ali A, Tariq I, Khan MA, Bakar MA
and Anwar AW: A clinical study and treatment results of
adrenocortical carcinoma patients presented in Shaukat Khanum
Memorial cancer hospital and research center, Lahore. J Pak Med
Assoc. 69:717–719. 2019.PubMed/NCBI
|
|
16
|
Goyal A, Malhotra R and Khadgawat R:
Precocious pseudopuberty due to virilising adrenocortical carcinoma
progressing to central precocious puberty after surgery. BMJ Case
Rep. 12(e229476)2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Shimelis D, Tadesse A, Schneider J and
Tilahun B: Adrenocortical carcinoma in a 3% years old girl with
hetro-sexual precocity. Ethiop Med J. 52:91–94. 2014.PubMed/NCBI
|
|
18
|
Miyoshi Y, Oue T, Oowari M, Soh H,
Tachibana M, Kimura S, Kiyohara Y, Yamada H, Bessyo K, Mushiake S,
et al: A case of pediatric virilizing adrenocortical tumor
resulting in hypothalamic-pituitary activation and central
precocious puberty following surgical removal. Endocr J.
56:975–982. 2009.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Takeuchi T, Yoto Y, Ishii A, Tsugawa T,
Yamamoto M, Hori T, Kamasaki H, Nogami K, Oda T, Nui A, et al:
Adrenocortical carcinoma characterized by gynecomastia: A case
report. Clin Pediatr Endocrinol. 27:9–18. 2018.PubMed/NCBI View
Article : Google Scholar
|
|
20
|
Ghazizadeh F, Ebadi M, Alavi S, Arzanian
M, Shamsian B and Jadali F: Adrenocortical carcinoma presenting
with heterosexual pseudoprecocious puberty shortly after birth:
Case report and review. Ecancermedicalscience.
7(289)2013.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Wendt S, Shelso J, Wright K and Furman W:
Neoplastic causes of abnormal puberty. Pediatr Blood Cancer.
61:664–671. 2014.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Idkowiak J, Elhassan YS, Mannion P, Smith
K, Webster R, Saraff V, Barrett TG, Shaw NJ, Krone N, Dias RP, et
al: Causes, patterns and severity of androgen excess in 487
consecutively recruited pre- and post-pubertal children. Eur J
Endocrinol. 180:213–221. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Tong A, Jiang J, Wang F, Li C, Zhang Y and
Wu X: Pure androgen-producing adrenal tumor: Clinical features and
pathogenesis. Endocr Pract. 23:399–407. 2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Fujisawa Y, Sakaguchi K, Ono H, Yamaguchi
R, Kato F, Kagami M, Fukami M and Ogata T: Combined steroidogenic
characters of fetal adrenal and Leydig cells in childhood
adrenocortical carcinoma. J Steroid Biochem Mol Biol. 159:86–93.
2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Chen QL, Su Z, Li YH, Ma HM, Chen HS and
Du ML: Clinical characteristics of adrenocortical tumors in
children. J Pediatr Endocrinol Metab. 24:535–541. 2011.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Jaruratanasirikul S, Patarapinyokul S and
Mitranun W: Androgen-producing adrenocortical carcinoma: Report of
3 cases with different clinical presentations. J Med Assoc Thai.
95:816–20. 2012.PubMed/NCBI
|
|
27
|
Mittal A, Aggarwal M and Debata P: Large
adrenocortical carcinoma presenting as an adenoma with precocious
puberty. Indian J Pediatr. 79:820–821. 2012.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Pinto EM, Chen X, Easton J, Finkelstein D,
Liu Z, Pounds S, Rodriguez-Galindo C, Lund TC, Mardis ER, Wilson
RK, et al: Genomic landscape of paediatric adrenocortical tumours.
Nat Commun. 6(6302)2015.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Yan G, Liu N, Tian J, Fu Y, Wei W, Zou J,
Li S, Wang Q, Li K and Wang J: Deubiquitylation and stabilization
of ARMC5 by ubiquitin-specific processing protease 7 (USP7) are
critical for RCC proliferation. J Cell Mol Med. 25:3149–3159.
2021.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Espiard S and Bertherat J: The genetics of
adrenocortical tumors. Endocrinol Metab Clin North Am. 44:311–334.
2015.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Jouinot A, Armignacco R and Assié G:
Genomics of benign adrenocortical tumors. J Steroid Biochem Mol
Biol. 193(105414)2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Daly MB, Pal T, Berry MP, Buys SS, Dickson
P, Domchek SM, Elkhanany A, Friedman S, Goggins M, Hutton ML, et
al: Genetic/familial high-risk assessment: Breast, ovarian, and
pancreatic, version 2.2021, NCCN clinical practice guidelines in
oncology. J Natl Compr Canc Netw. 19:77–102. 2021.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Ferreira AM, Brondani VB, Helena VP,
Charchar HLS, Zerbini MCN, Leite LAS, Hoff AO, Latronico AC,
Mendonca BB, Diz MDPE, et al: Clinical spectrum of Li-Fraumeni
syndrome/Li-Fraumeni-like syndrome in Brazilian individuals with
the TP53 p.R337H mutation. J Steroid Biochem Mol Biol. 190:250–255.
2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Brenna CTA, Michaeli O, Wasserman JD and
Malkin D: Clinical outcomes of children with adrenocortical
carcinoma in the context of germline TP53 status. J Pediatr Hematol
Oncol. 43:e635–e641. 2021.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Costa TEJ, Gerber VKQ, Ibañez HC, Melanda
VS, Parise IZS, Watanabe FM, Pianovski MAD, Fiori CMCM, Fabro ALMR,
Silva DBD, et al: Penetrance of the TP53 R337H mutation and
pediatric adrenocortical carcinoma incidence associated with
environmental influences in a 12-year observational cohort in
Southern Brazil. Cancers (Basel). 11(1804)2019.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Kostiainen I, Hakaste L, Kejo P,
Parviainen H, Laine T, Löyttyniemi E, Pennanen M, Arola J, Haglund
C, Heiskanen I and Schalin-Jäntti C: Adrenocortical carcinoma:
Presentation and outcome of a contemporary patient series.
Endocrine. 65:166–174. 2019.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Parise IZS, Parise GA, Noronha L, Surakhy
M, Woiski TD, Silva DB, Costa TEB, Del-Valle MHCP, Komechen H,
Rosati R, et al: The prognostic role of CD8+ T
lymphocytes in childhood adrenocortical carcinomas compared to
Ki-67, PD-1, PD-L1, and the weiss score. Cancers (Basel).
11(1730)2019.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Raymond VM, Everett JN, Furtado LV,
Gustafson SL, Jungbluth CR, Gruber SB, Hammer GD, Stoffel EM,
Greenson JK, Giordano TJ and Else T: Adrenocortical carcinoma is a
lynch syndrome-associated cancer. J Clin Oncol. 31:3012–3018.
2013.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Domènech M, Grau E, Solanes A, Izquierdo
A, Del Valle J, Carrato C, Pineda M, Dueñas N, Pujol M, Lázaro C,
et al: characteristics of adrenocortical carcinoma associated with
lynch syndrome. J Clin Endocrinol Metab. 106:318–325.
2021.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Sung JY, Lim HW, Joung JG and Park WY:
Pan-cancer analysis of alternative lengthening of telomere
activity. Cancers (Basel). 12(2207)2020.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Borges KS, Pignatti E, Leng S, Kariyawasam
D, Ruiz-Babot G, Ramalho FS, Taketo MM, Carlone DL and Breault DT:
Wnt/β-catenin activation cooperates with loss of p53 to cause
adrenocortical carcinoma in mice. Oncogene. 39:5282–5291.
2020.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Rubin B, Regazzo D, Redaelli M, Mucignat
C, Citton M, Iacobone M, Scaroni C, Betterle C, Mantero F, Fassina
A, et al: Investigation of N-cadherin/β-catenin expression in
adrenocortical tumors. Tumour Biol. 37:13545–13555. 2016.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Peng H, Jenkins ZA, White R, Connors S,
Hunter MF, Ronan A, Zankl A, Markie DM, Daniel PB and Robertson SP:
An activating variant in CTNNB1 is associated with a sclerosing
bone dysplasia and adrenocortical neoplasia. J Clin Endocrinol
Metab. 105(dgaa034)2020.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Cöktü S, Spix C, Kaiser M, Beygo J,
Kleinle S, Bachmann N, Kohlschmidt N, Prawitt D, Beckmann A, Klaes
R, et al: Cancer incidence and spectrum among children with
genetically confirmed Beckwith-Wiedemann spectrum in Germany: A
retrospective cohort study. Br J Cancer. 123:619–623.
2020.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Pinto EM, Faucz FR, Paza LZ, Wu G,
Fernandes ES, Bertherat J, Stratakis CA, Lalli E, Ribeiro RC,
Rodriguez-Galindo C, et al: Germline variants in phosphodiesterase
genes and genetic predisposition to pediatric adrenocortical
tumors. Cancers (Basel). 12(506)2020.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Surakhy M, Wallace M, Bond E, Grochola LF,
Perez H, Di Giovannantonio M, Zhang P, Malkin D, Carter H, Parise
IZS, et al: A common polymorphism in the retinoic acid pathway
modifies adrenocortical carcinoma age-dependent incidence. Br J
Cancer. 122:1231–1241. 2020.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Harada K, Yasuda M, Hasegawa K, Yamazaki
Y, Sasano H and Otsuka F: A novel case of myxoid variant of
adrenocortical carcinoma in a patient with multiple endocrine
neoplasia type 1. Endocr J. 66:739–744. 2019.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Wang W, Han R, Ye L, Xie J, Tao B, Sun F,
Zhuo R, Chen X, Deng X, Ye C, et al: Adrenocortical carcinoma in
patients with MEN1: A kindred report and review of the literature.
Endocr Connect. 8:230–238. 2019.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Al-Salameh A, Cadiot G, Calender A, Goudet
P and Chanson P: Clinical aspects of multiple endocrine neoplasia
type 1. Nat Rev Endocrinol. 17:207–224. 2021.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Else T and Rodriguez-Galindo C: 5th
International ACC Symposium: Hereditary predisposition to childhood
ACC and the associated molecular phenotype: 5th International ACC
symposium session: Not just for kids! Horm Cancer. 7:36–39.
2016.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Li J, Zhang W, Hu H, Zhang Y, Wen Y and
Huang D: Adrenocortical carcinoma in eight children: A report and
literature review. Cancer Manag Res. 13:1307–1314. 2021.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Martins-Filho SN, Almeida MQ, Soares I,
Wakamatsu A, Alves VAF, Fragoso MCBV and Zerbini MCN: Clinical
impact of pathological features including the Ki-67 labeling index
on diagnosis and prognosis of adult and pediatric adrenocortical
tumors. Endocr Pathol. 32:288–300. 2021.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Zhang F, Zhang F, Liu Z, Wu K, Zhu Y and
Lu Y: Prognostic role of Ki-67 in adrenocortical carcinoma after
primary resection: A retrospective mono-institutional study. Adv
Ther. 36:2756–2768. 2019.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Beuschlein F, Weigel J, Saeger W, Kroiss
M, Wild V, Daffara F, Libé R, Ardito A, Al Ghuzlan A, Quinkler M,
et al: Major prognostic role of Ki67 in localized adrenocortical
carcinoma after complete resection. J Clin Endocrinol Metab.
100:841–849. 2015.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Yamazaki Y, Nakamura Y, Shibahara Y,
Konosu-Fukaya S, Sato N, Kubota-Nakayama F, Oki Y, Baba S,
Midorikawa S, Morimoto R, et al: Comparison of the methods for
measuring the Ki-67 labeling index in adrenocortical carcinoma:
Manual versus digital image analysis. Hum Pathol. 53:41–50.
2016.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Papathomas TG, Pucci E, Giordano TJ, Lu H,
Duregon E, Volante M, Papotti M, Lloyd RV, Tischler AS, van
Nederveen FH, et al: An international Ki67 reproducibility study in
adrenal cortical carcinoma. Am J Surg Pathol. 40:569–576.
2016.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Ardicli B, User IR, Ciftci AO, Akyuz C,
Kutluk MT, Yalcin B, Gonc N, Ozon ZA, Alikasifoglu A, Oguz B, et
al: Adrenocortical tumours in children: A review of surgical
management at a tertiary care centre. ANZ J Surg. 91:992–999.
2021.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Orbach L, Nachmany I, Goykhman Y, Lahat G,
Yossepowitch O, Beri A, Ben-Gal Y, Klausner JM and Lubezky N:
Surgical approach to abdominal tumors involving the inferior vena
cava. Isr Med Assoc J. 22:364–368. 2020.PubMed/NCBI
|
|
59
|
Mirsharifi A, Vasei M, Sadeghian E,
Ghorbani-Abdehgah A and Naybandi Atashi S: Extra-adrenal,
non-functional adrenocortical carcinoma presenting with acute
abdomen: A case report. J Med Case Rep. 14(107)2020.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Zambaiti E, Duci M, De Corti F, Gamba P,
Dall'Igna P, Ghidini F and Virgone C: Clinical prognostic factors
in pediatric adrenocortical tumors: A meta-analysis. Pediatr Blood
Cancer. 68(e28836)2021.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Kwon A, Choi Y, Jung JW, Suh J and Kim HS:
Using etomidate in a 2-month-old infant with cushing syndrome due
to adrenocortical carcinoma. J Clin Res Pediatr Endocrinol 2020
(Epub ahead of print).
|
|
62
|
Oddie PD, Albert BB, Hofman PL, Jefferies
C, Laughton S and Carter PJ: Mitotane in the treatment of childhood
adrenocortical carcinoma: A potent endocrine disruptor. Endocrinol
Diabetes Metab Case Rep. 2018:18–0059. 2018.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Gupta N, Rivera M, Novotny P, Rodriguez V,
Bancos I and Lteif A: Adrenocortical carcinoma in children: A
clinicopathological analysis of 41 patients at the mayo clinic from
1950 to 2017. Horm Res Paediatr. 90:8–18. 2018.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Cecchetto G, Ganarin A, Bien E, Vorwerk P,
Bisogno G, Godzinski J, Dall'Igna P, Reguerre Y, Schneider D,
Brugières L, et al: Outcome and prognostic factors in high-risk
childhood adrenocortical carcinomas: A report from the European
Cooperative Study Group on Pediatric Rare Tumors (EXPeRT). Pediatr
Blood Cancer. 64:2017.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Duregon E, Cappellesso R, Maffeis V,
Zaggia B, Ventura L, Berruti A, Terzolo M, Fassina A, Volante M and
Papotti M: Validation of the prognostic role of the ‘Helsinki
Score’ in 225 cases of adrenocortical carcinoma. Hum Pathol.
62:1–7. 2017.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Bulzico D, de Faria PA, de Paula MP,
Bordallo MA, Pessoa CH, Corbo R, Ferman S, Vaisman M and Neto LV:
Recurrence and mortality prognostic factors in childhood
adrenocortical tumors: Analysis from the Brazilian National
Institute of Cancer experience. Pediatr Hematol Oncol. 33:248–258.
2016.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Gulack BC, Rialon KL, Englum BR, Kim J,
Talbot LJ, Adibe OO, Rice HE and Tracy ET: Factors associated with
survival in pediatric adrenocortical carcinoma: An analysis of the
National cancer data base (NCDB). J Pediatr Surg. 51:172–177.
2016.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Dias AI, Fachin CG, Avó LR, Frazão CV,
Caran EM, Schettini ST, Alves MT, Ribeiro RC and Abib Sde C:
Correlation between selected angiogenic markers and prognosis in
pediatric adrenocortical tumors: Angiogenic markers and prognosis
in pediatric ACTs. J Pediatr Surg. 50:1323–1328. 2015.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Rahat-Ul-Ain. Acquired pulmonary
arteriovenous malformation in a case of a pediatric adrenocortical
carcinoma. J Coll Physicians Surg Pak. 31:119–120. 2021.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Doghman-Bouguerra M, Finetti P, Durand N,
Parise IZS, Sbiera S, Cantini G, Canu L, Hescot S, Figueiredo MMO,
Komechen H, et al: Cancer-testis antigen fate1 expression in
adrenocortical tumors is associated with a pervasive autoimmune
response and is a marker of malignancy in adult, but not children,
ACC. Cancers (Basel). 12(689)2020.PubMed/NCBI View Article : Google Scholar
|
